Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
27
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Clover Health Investments
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Digital Healthcare And Medicare Advantage Will Unlock Long-term Opportunities
Key Takeaways Clover's technology-driven care model and expanding platform could yield outsized membership growth, recurring revenue, and strengthened margins as competitors retreat from wide-network PPO offerings. Enhanced data access and platform initiatives may unlock significant multi-sided platform economics, positioning Clover for durable advantage amid industry shifts toward value-based reimbursement and home care.
View narrative
US$5.00
FV
45.4% undervalued
intrinsic discount
25.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Organogenesis Holdings
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Expanding Advanced Wound Care Will Fuel Secular Demand
Key Takeaways Upcoming CMS reimbursement and LCD changes will give Organogenesis a significant market share and margin advantage over competitors due to its portfolio strength. New product launches and clinical data investments position the company for sustained revenue growth, improved payer relationships, and long-term market dominance.
View narrative
US$9.00
FV
45.7% undervalued
intrinsic discount
25.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Stanley Black & Decker
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
Home Improvement And Urbanization Will Power Digital Tool Surge
Key Takeaways Breakthrough operational efficiencies and rapid localization are expected to structurally boost margins and reset profitability above historical levels. Sustained innovation, pro-focused tools, and digital solutions position the company for strong market share gains and above-consensus long-term growth across regions.
View narrative
US$113.87
FV
31.9% undervalued
intrinsic discount
5.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Travere Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
FILSPARI Expansion And Aging Trends Will Advance Precision Therapies
Key Takeaways Rapid market adoption, limited competition, and clinical leadership uniquely position Travere to achieve dominance and pricing power in rare kidney disease therapies. Strong operational execution and favorable industry trends support robust revenue growth, superior margins, and a resilient, cash-generative business model.
View narrative
US$47.00
FV
61.9% undervalued
intrinsic discount
45.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Diös Fastigheter
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Renovations And Green Transition Will Transform Northern Sweden Markets
Key Takeaways Strategic focus on centrally located, sustainable properties in growth markets supports stable revenues, high occupancy, and long-term rental income growth. Operational enhancements and proactive refinancing strengthen margins, cash flows, and earnings resilience despite inflationary and economic uncertainties.
View narrative
SEK 87.00
FV
24.0% undervalued
intrinsic discount
4.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
New
narrative
Keystone Realtors
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Sion And Lokhandwala Redevelopment Will Transform Mumbai Real Estate
Key Takeaways Expanding high-value projects and efficient execution support strong revenue growth, consistent earnings, and margin improvement amid robust demand and urbanization trends. Strong balance sheet and strategic market focus enable leadership consolidation, cost efficiency, and capitalize on digitization for future growth and competitive advantage.
View narrative
₹866.67
FV
24.9% undervalued
intrinsic discount
22.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Max Estates
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Urbanization Trends In Delhi NCR Will Boost Real Estate Activity
Key Takeaways Robust demand and shifting preferences for premium, tech-enabled spaces drive strong growth, higher occupancy, and recurring rental income across residential and commercial portfolios. Prudent development strategy, solid cash flows, and favourable policy trends minimize risk while enabling scalable, self-funded expansion and stronger project valuations.
View narrative
₹720.20
FV
36.2% undervalued
intrinsic discount
64.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
Alpargatas
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Premium Footwear And Digital Channels Will Expand Global Reach
Key Takeaways Strong brand positioning, digital expansion, and operational improvements are driving revenue growth, higher margins, and earnings stability. Global collaborations and sustainability focus enhance brand equity, supporting premiumization and long-term market expansion.
View narrative
R$10.38
FV
8.9% undervalued
intrinsic discount
6.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
BellRing Brands
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Expanding Retail Access And RTD Shakes Will Open Future Markets
Key Takeaways Category leadership and expanded retail presence drive sustained revenue growth and margin gains through greater scale and distribution. Innovation, supply chain optimization, and targeted marketing strengthen brand equity, address evolving consumer trends, and support long-term earnings growth.
View narrative
US$52.50
FV
24.0% undervalued
intrinsic discount
8.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies